Ftse Mib
34.242,49
0,75%
DAX
18.430,05
1,42%
S&P 500
5.187,70
0,13%
NASDAQ
16.332,56
-0,10%
Bitcoin
62.478,37
-1,09%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 180 Life Sciences Corporation (ATNF) 180 Life Sciences Corporation (ATNF) Notizie

180 Life Sciences Corporation

ATNF
2,01
0,14 (7,49%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:47:36
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/3/202413:30GLOBE180 Life Sciences Regains Full Compliance with Nasdaq ..
11/3/202412:03EDGAR2Form 8-K - Current report
08/3/202422:49EDGAR2Form 8-K - Current report
29/2/202414:00EDGAR2Form 8-K - Current report
28/2/202412:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202412:39EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202412:37EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202412:30EDGAR2Form 8-K - Current report
26/2/202413:00EDGAR2Form 8-K - Current report
26/2/202413:00GLOBE180 Life Sciences Corp. Announces 1-For 19 Reverse Stock..
20/2/202414:01EDGAR2Form 8-K - Current report
16/2/202423:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202423:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202423:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202422:15EDGAR2Form 8-K - Current report
12/2/202422:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/1/202423:29EDGAR2Form S-1 - General form for registration of securities under..
29/1/202414:00EDGAR2Form 8-K - Current report
17/1/202414:30EDGAR2Form 8-K - Current report
16/1/202414:30EDGAR2Form 8-K - Current report
29/12/202300:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/12/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
21/12/202323:00EDGAR2Form 8-K - Current report
20/12/202314:00EDGAR2Form 8-K - Current report
18/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:30EDGAR2Form 8-K - Current report
14/12/202322:30EDGAR2Form PRE 14A - Other preliminary proxy statements
04/12/202315:00EDGAR2Form 8-K - Current report
04/12/202315:00GLOBE180 Life Sciences Engages Financial Advisor to Explore..
30/11/202323:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/11/202323:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/11/202314:10EDGAR2Form 8-K - Current report
28/11/202315:00EDGAR2Form 8-K - Current report
28/11/202315:00GLOBE180 Life Sciences Announces Review of Strategic Alternatives
16/11/202322:30EDGAR2Form 8-K - Current report
09/11/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/10/202322:33EDGAR2Form 8-K - Current report
13/10/202323:00EDGAR2Form 8-K - Current report
28/9/202322:18EDGAR2Form 8-K - Current report
22/9/202315:00EDGAR2Form 8-K - Current report
08/9/202322:30EDGAR2Form 8-K - Current report
08/9/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202314:30EDGAR2Form 8-K - Current report
07/9/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202300:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/8/202323:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202323:26EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
Apertura: 1,90 Min: 1,90 Max: 2,3583
Chiusura: 1,87

La tua Cronologia

NASDAQ
ATNF
180 Life Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network